Neuro-oncology experts release clinical practice guidelines for using AI in brain cancer diagnosis, monitoring, treatment

Beyond the $500B Stargate Project: The frontier of AI in oncology beckons

On Jan. 21, President Donald Trump announced the launch of the Stargate Project, a $500 billion artificial intelligence infrastructure project designed to revolutionize healthcare.

January 24, 2025

Vol.51 No.03

By Sorena Nadaf-Rahrov

Guest Editorial

FDA and OHRP draft guidance aims to improve ethics of tissue biopsies in clinical trials

The U.S. Food and Drug Administration and the U.S. Department of Health and Human Services Office of Human Research Protections issued Draft Guidance on the inclusion of tissue biopsies in clinical trials.

January 17, 2025

Vol.51 No.02

By Laura A. Levit, Mark J. Ratain, Julie R. Gralow, Clifford A. Hudis and Elizabeth Garrett-Mayer

Clinical

NCCN publishes patient resource on genetic testing to guide patient decisionmaking

The National Comprehensive Cancer Network published its first patient resource aimed at informing people about the latest recommendations around hereditary and familial cancer risk. The document provides guidance on testing for inherited genetic mutations that can raise the risk of cancer.

NCCN guidelines updated to include ctDNA-MRD testing recommendation for B-cell lymphoma

The National Comprehensive Cancer Network included circulating tumor DNA testing in their Clinical Practice Guidelines in Oncology for diffuse large B-cell lymphoma. This marks the first-ever inclusion of ctDNA-MRD testing in these guidelines, representing a significant advancement in lymphoma patient care.

January 17, 2025

Vol.51 No.02

Clinical Roundup

AI improves breast cancer diagnosis

Artificial Intelligence can improve breast cancer detection and reduce workload on physicians, according to a new study featuring over 461,000 women. The research published in the journal Nature Medicine looked at integrating an AI tool as part of a national screening program for women without symptoms of breast cancer in Germany.

January 17, 2025

Vol.51 No.02

Drugs & Targets

N-Power Medicine acquires Syapse to expand network for oncology clinical research, trials

N-Power Medicine announced the acquisition of Syapse Holdings Inc. The integration of Syapse into N-Power Medicine incorporates Syapse’s network of community-based health systems, with more than 1,000 oncologists, its data and technology stack, and its team.

January 17, 2025

Vol.51 No.02

Neuro-oncology experts release clinical practice guidelines for using AI in brain cancer diagnosis, monitoring, treatment

YOU MAY BE INTERESTED IN

Beyond the $500B Stargate Project: The frontier of AI in oncology beckons

FDA and OHRP draft guidance aims to improve ethics of tissue biopsies in clinical trials

NCCN publishes patient resource on genetic testing to guide patient decisionmaking

NCCN guidelines updated to include ctDNA-MRD testing recommendation for B-cell lymphoma

AI improves breast cancer diagnosis

N-Power Medicine acquires Syapse to expand network for oncology clinical research, trials

Renew today!

Subscriber content

Never miss an issue!

Login